Berberine nanoencapsulation attenuates hallmarks of scoplomine induced Alzheimer's-like disease in rats.

CONCLUSIONS: The enhancing effect of BBR- NPs could be related to the enhancing of its bioavailability, absorption and brain drug uptake which need more investigation in future work.
PMID: 32598269 [PubMed - as supplied by publisher]

Source: Current Clinical Pharmacology - June 27, 2020 Category: Drugs & Pharmacology Authors: Saleh SR, Abady MM, Nofal M, Yassa NW, Abdel-Latif MS, Nounou MI, Ghareeb DA, Abdel-Monaem N Tags: Curr Clin Pharmacol Source Type: research